Perhexiline |
100 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
Perhexiline |
200 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
Perhexiline |
400 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
Perhexiline |
100 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
193 |
Perhexiline |
200 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
Perhexiline |
400 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
Perhexiline |
200 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
erlotinib |
17.4 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
increase |
Positive |
EC20 |
36 |
Fluconazole |
186.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Pioglitazone |
|
|
|
|
|
decrease |
Positive |
|
22 |
Pioglitazone |
|
|
|
|
|
decrease |
Positive |
|
22 |
promethazine |
|
|
|
|
|
increase |
Positive |
|
22 |
clomipramine |
|
|
|
|
|
increase |
Positive |
|
22 |
clomipramine |
|
|
|
|
|
decrease |
Positive |
|
22 |
imipramine |
|
|
|
|
|
increase |
Positive |
|
22 |
Chlorpromazine |
|
|
|
|
|
increase |
Positive |
|
22 |
Chlorpromazine |
|
|
|
|
|
decrease |
Positive |
|
22 |
Chlorpromazine |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
23 |
Haloperidol |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
23 |
Risperidone |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
23 |
quetiapine |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
23 |
Antimycin A |
|
|
|
|
|
decrease |
Positive |
|
26 |
Myxothiazol |
|
|
bovine |
heart mitochondria |
|
decrease |
Positive |
|
29 |
Papaverine |
|
|
|
|
|
decrease |
Positive |
|
30 |
Lamivudine |
317.4 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Thenoyltrifluoroacetone |
|
|
|
|
|
decrease |
Positive |
|
33 |
Acetaminophen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Acetaminophen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Lidocaine |
188.2 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
increase |
Positive |
EC20 |
36 |
Acetylsalicylic acid |
|
|
|
|
|
decrease |
Positive |
|
35 |
Acetylsalicylic acid |
|
|
|
|
|
decrease |
Positive |
|
35 |
Flutamide |
|
|
|
|
|
decrease |
Positive |
|
35 |
Ketoconazole |
|
|
|
|
|
decrease |
Positive |
|
35 |
mefloquine |
|
|
|
|
|
decrease |
Positive |
|
35 |
lovastatin |
6.2 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Metformin |
|
|
|
|
|
decrease |
Positive |
|
35 |
Nefazodone |
|
|
|
|
|
decrease |
Positive |
|
35 |
lumiracoxib |
12 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Nitrofurantoin |
|
|
|
|
|
decrease |
Positive |
|
35 |
Paraquat |
|
|
|
|
|
decrease |
Positive |
|
35 |
paroxetine |
|
|
|
|
|
decrease |
Positive |
|
35 |
paroxetine |
|
|
|
|
|
decrease |
Positive |
|
35 |
paroxetine |
|
|
|
|
|
decrease |
Positive |
|
35 |
paroxetine |
|
|
|
|
|
decrease |
Positive |
|
35 |
Manganese |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Phenformin |
|
|
|
|
|
decrease |
Positive |
|
35 |
Pioglitazone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Pioglitazone |
|
|
|
|
|
decrease |
Positive |
|
35 |
promethazine |
|
|
|
|
|
decrease |
Positive |
|
35 |
Rosiglitazone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Rotenone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Metformin |
351.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Troglitazone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Antimycin A |
|
|
|
|
|
decrease |
Positive |
|
35 |
Myxothiazol |
|
|
|
|
|
decrease |
Positive |
|
35 |
Oligomycin |
|
|
|
|
|
decrease |
Positive |
|
35 |
Nicotine |
312 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Thenoyltrifluoroacetone |
|
|
|
|
|
decrease |
Positive |
|
35 |
alpidem |
|
|
|
|
|
decrease |
Positive |
|
36 |
nifuroxazide |
3.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Amiodarone |
|
|
|
|
|
decrease |
Positive |
|
36 |
benzbromarone |
|
|
|
|
|
decrease |
Positive |
|
37 |
Chlorpromazine |
|
|
|
|
|
decrease |
Positive |
|
7 |
clomipramine |
|
|
|
|
|
decrease |
Positive |
|
38 |
Diclofenac |
|
|
|
|
|
decrease |
Positive |
|
39 |
Flutamide |
|
|
|
|
|
decrease |
Positive |
|
41 |
Nitrofurantoin |
8.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Ketoconazole |
|
|
|
|
|
decrease |
Positive |
|
36 |
lovastatin |
|
|
|
|
|
decrease |
Positive |
|
36 |
Perhexiline |
87.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Phenformin |
|
|
|
|
|
decrease |
Positive |
|
43 |
Rosiglitazone |
|
|
|
|
|
decrease |
Positive |
|
7 |
Simvastatin |
|
|
|
|
|
decrease |
Positive |
|
7 |
Piroxicam |
6.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
sitaxsentan |
|
|
|
|
|
decrease |
Positive |
|
44 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
46 |
Troglitazone |
|
|
|
|
|
decrease |
Positive |
|
7 |
Doxorubicin |
|
|
|
|
|
decrease |
Positive |
|
36 |
propylparaben |
28.4 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
imipramine |
|
|
|
|
|
decrease |
Positive |
|
36 |
sertraline |
|
|
|
|
|
decrease |
Positive |
|
48 |
zoniporide |
|
|
|
|
|
decrease |
Positive |
|
50 |
Pyrazinamide |
190.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
pentamidine |
|
|
|
|
|
decrease |
Positive |
|
51 |
ritonavir |
|
|
|
|
|
decrease |
Positive |
|
36 |
Tenofovir |
|
|
|
|
|
decrease |
Positive |
|
52 |
Polymyxin B |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
beclomethasone |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
bicalutamide |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
danazol |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
ethynodiol diacetate |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
riboflavin |
182.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
retinoic acid |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
aripiprazole |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
axitinib |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
clofilium |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
tenidap |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
darifenacin |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
pimozide |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
Tamoxifen |
15 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
IC50 |
3 |
Gemfibrozil |
|
|
|
isolated mitochondria |
|
decrease |
Positive |
|
7 |
Amitriptyline |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
60 |
Bupivacaine |
|
|
|
|
|
decrease |
Positive |
|
61 |
citalopram |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
62 |
citalopram |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
62 |
citalopram |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
62 |
Haloperidol |
|
|
|
|
|
decrease |
Positive |
|
23 |
propranolol |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
60 |
Indomethacin |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
65 |
ochratoxin a |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
66 |
tacrolimus |
|
|
rat |
isolated kidney mitochondria |
|
decrease |
Positive |
|
68 |
Troglitazone |
6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Piericidin A |
|
|
|
|
|
affect |
Positive |
|
53 |
rolliniastatin-2 |
|
|
|
|
|
affect |
Positive |
|
53 |
Idebenone |
|
|
|
|
|
affect |
Positive |
|
53 |
Rotenone |
|
|
|
|
|
affect |
Positive |
|
53 |
piericidin a |
|
|
|
|
|
affect |
Positive |
|
53 |
piericidin b |
|
|
|
|
|
affect |
Positive |
|
53 |
aureothin |
|
|
|
|
|
affect |
Positive |
|
53 |
amytal |
|
|
|
|
|
affect |
Positive |
|
53 |
4-alkyl-acridones |
|
|
|
|
|
affect |
Positive |
|
53 |
4′-alkyl-mpp+ analoguesc |
|
|
|
|
|
affect |
Positive |
|
53 |
phenoxan |
|
|
|
|
|
affect |
Positive |
|
53 |
quinol products |
|
|
|
|
|
affect |
Positive |
|
53 |
reduced q-2b |
|
|
|
|
|
affect |
Positive |
|
53 |
Myxothiazol |
|
|
|
|
|
affect |
Positive |
|
53 |
stigmatellin |
|
|
|
|
|
affect |
Positive |
|
53 |
TDS |
|
|
|
|
|
affect |
Positive |
|
53 |
2M-TIO |
|
|
|
|
|
affect |
Positive |
|
53 |
meperidine |
|
|
|
|
|
affect |
Positive |
|
53 |
para-nonylphenol |
|
|
|
|
|
affect |
Positive |
|
53 |
Diphenyleneiodonium chloride |
|
|
|
|
|
affect |
Positive |
|
69 |
ethoxyformic anhydride |
|
|
|
|
|
affect |
Positive |
|
70 |
ethoxyformic anhydride |
|
|
|
|
|
decrease |
Positive |
|
70 |
ethoxyformic anhydride |
|
|
|
|
|
decrease |
Positive |
|
70 |
flutolanil |
|
|
|
|
|
affect |
Positive |
|
71 |
atpenin a5 |
|
|
|
|
|
affect |
Positive |
|
71 |
Carboxin |
|
|
|
|
|
affect |
Positive |
|
71 |
penthiopyrad |
|
|
|
|
|
affect |
Positive |
|
71 |
boscalid |
|
|
|
|
|
affect |
Positive |
|
71 |
fluopyram |
|
|
|
|
|
affect |
Positive |
|
71 |
dinitrophenol-17 |
|
|
|
|
|
affect |
Positive |
|
71 |
atpenin a5 |
|
|
|
|
|
affect |
Positive |
|
72 |
thiophene carboxamides |
|
|
|
|
|
affect |
Positive |
|
73 |
HQNO |
|
|
|
|
|
affect |
Positive |
|
74 |
Polymyxin B |
1.6 μg/ml |
|
Mycobacterium smegmatis |
membrane-bound dehydrogenases |
|
decrease |
Positive |
IC50 |
76 |
nanaomycin a |
31 μg/ml |
|
Mycobacterium smegmatis |
membrane-bound dehydrogenases |
|
decrease |
Positive |
IC50 |
76 |
siccanin |
|
|
P. aeruginosa |
PAO1 cells |
|
affect |
Positive |
|
76 |
cyenopyrafen |
|
|
|
|
|
affect |
Positive |
|
77 |
pyflubumide |
|
|
|
|
|
affect |
Positive |
|
77 |
3-Nitropropionate |
|
|
|
|
|
affect |
Positive |
|
78 |
Malonate |
|
|
|
|
|
affect |
Positive |
|
79 |
british anti-lewisite |
|
|
|
|
|
affect |
Positive |
|
80 |
Myxothiazol |
|
|
|
|
|
affect |
Positive |
|
81 |
moas |
|
|
|
|
|
affect |
Positive |
|
82 |
azoxystrobin |
|
|
|
|
|
affect |
Positive |
|
83 |
oudemansin a |
|
|
|
|
|
affect |
Positive |
|
84 |
strobilurin a |
|
|
|
|
|
affect |
Positive |
|
84 |
cpmb-oxime |
|
|
|
|
|
affect |
Positive |
|
84 |
azoxystrobin |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
famoxadone |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
stigmatellin |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
uhdbt |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
hhdbt uhnq |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
dibromothymoquinone |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
Antimycin A |
|
|
bovine |
isolated heart mitochondria cytochrome bc1 complex |
|
affect |
Positive |
|
166 |
diuron |
|
|
|
|
|
affect |
Positive |
|
83 |
NQNO |
|
|
bovine |
isolated heart mitochondria cytochrome bc1 complex |
|
affect |
Positive |
|
166 |
NQNO |
|
|
bovine |
isolated heart mitochondria cytochrome bc1 complex |
|
affect |
Positive |
|
166 |
Carbon Monoxide |
|
|
|
|
|
affect |
Positive |
|
167 |
nitric oxide |
|
|
|
|
|
affect |
Positive |
|
167 |
Cyanide |
|
|
|
|
|
affect |
Positive |
|
167 |
azides |
|
|
|
|
|
affect |
Positive |
|
167 |
sulfide |
|
|
|
|
|
affect |
Positive |
|
167 |
formate |
|
|
|
|
|
affect |
Positive |
|
167 |
ethylxanthate |
|
|
|
|
|
affect |
Positive |
|
167 |
bisulfate |
|
|
|
|
|
affect |
Positive |
|
167 |
semicarbazide |
|
|
|
|
|
affect |
Positive |
|
167 |
salicyaldoxime |
|
|
|
|
|
affect |
Positive |
|
167 |
ethylxanthate |
|
|
|
|
|
decrease |
Positive |
|
167 |
bisulfate |
|
|
|
|
|
decrease |
Positive |
|
167 |
semicarbazide |
|
|
|
|
|
decrease |
Positive |
|
167 |
salicyaldoxime |
|
|
|
|
|
decrease |
Positive |
|
167 |
adda 5 |
|
|
human |
U251 mitochondria |
CcO activity assay |
affect |
Positive |
|
168 |
tetrathiomolybdate |
30 μM |
48 hour |
human |
ECC-1 |
|
affect |
Positive |
|
169 |
tetrathiomolybdate |
30 μM |
48 hour |
human |
IGROV-1 |
|
affect |
Positive |
|
169 |
Oligomycin |
152 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle, pH gradient formation |
|
affect |
Positive |
|
170 |
Oligomycin |
7.1 μg inhibitor/mg protein |
|
C. asciculate |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
Oligomycin |
2.0-3.0 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
Oligomycin |
0.3 μM |
|
human NCI-60 cell lines |
F0F1-ATPase |
|
affect |
Positive |
IC50 |
170 |
Oligomycin |
15 ng inhibitor/mg protein |
|
N. crassa |
SMP-ATPase |
|
affect |
Positive |
Ki |
170 |
Oligomycin |
0.21 μM |
|
bovine |
heart MF0F1-ATPase |
|
affect |
Positive |
Ki |
170 |
Oligomycin |
0.4 μg inhibitor/mg protein |
|
bovine |
heart SMP-ATPase |
|
affect |
Positive |
95% inhibition |
170 |
Oligomycin |
0.5 μg/ml |
|
rat |
liver SMP-ATPase |
|
affect |
Positive |
75% inhibition |
170 |
ossamycin |
46 μg of inhibitor/mg protein |
|
E. coli |
pH gradient formation by membrane vesicle |
|
affect |
Positive |
IC50 |
170 |
ossamycin |
8 μM |
|
human NCI-60 cell lines |
F0F1-ATPase |
|
affect |
Positive |
IC50 |
170 |
ossamycin |
1.3 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
venturicidin B |
|
|
|
|
|
affect |
Positive |
|
170 |
Bedaquiline |
|
|
|
|
|
affect |
Positive |
|
170 |
tributyltin chloride |
200 nM |
|
E. coli and |
F0F1-ATPase |
|
affect |
Positive |
|
170 |
tributyltin chloride |
200 nM |
|
I. tartaricus |
F0F1-ATPase |
|
affect |
Positive |
|
170 |
tributyltin chloride |
1 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
affect |
Positive |
47% inhibition |
170 |
tributyltin chloride |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
affect |
Positive |
87% inhibition |
170 |
tributyltin chloride |
1 μM |
|
|
TF0F1-ATPase |
|
affect |
Positive |
80% inhibition |
170 |
NCCD |
0.65 nmol/mg protein |
|
bovine |
heart SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
NCCD |
1 nmol NCCD/mg protein |
|
bovine |
heart SMP-ATPase |
|
affect |
Positive |
85% inhibition |
170 |
substrate analogs |
|
|
|
|
|
affect |
Positive |
|
170 |
tentoxin |
∼0.6 mol/mol |
|
spinach |
CF1-ATPase |
|
affect |
Positive |
IC50 |
170 |
tentoxin |
50 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
affect |
Positive |
IC50 |
170 |
tentoxin |
0.4-0.6 μM |
|
lettuce |
chloroplasts, photophosphorylation |
|
affect |
Positive |
IC50 |
170 |
tentoxin |
10 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
affect |
Positive |
Ki |
170 |
tentoxin |
30-60 μM |
|
|
TF1-ATPase |
|
affect |
Positive |
Ki |
170 |
tentoxin |
8-10 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
affect |
Positive |
Kd |
170 |
efrapeptins |
|
|
|
|
|
affect |
Positive |
|
170 |
azide |
|
|
|
|
|
affect |
Positive |
|
170 |
resveratrol |
|
|
|
|
|
affect |
Positive |
|
170 |
N,N'-dicyclohexylcarbodiimide |
0.2 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
N,N'-dicyclohexylcarbodiimide |
1-5 μg of inhibitor/mg protein |
|
T. pyriformis |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
N,N'-dicyclohexylcarbodiimide |
200 μMa in less than 5 min and at ∼40 μMa in 30 min |
|
R. rubrum |
F1-ATPase |
|
affect |
Positive |
|
170 |
N,N'-dicyclohexylcarbodiimide |
1.9 μg/mg protein |
|
C. fasciculata |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
N,N'-dicyclohexylcarbodiimide |
1 mol DCCD/mol F1 |
|
|
EF1-ATPase |
|
affect |
Positive |
95% inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
30 μM |
|
|
membrane-bound EF0F1-ATPase |
|
affect |
Positive |
maximal 70-80% inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
affect |
Positive |
47% inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
2 mol inhibitor bound/mol F1 |
|
bovine |
heart MF1-ATPase |
|
affect |
Positive |
97% inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
1 mol inhibitor/mol F0 |
|
bovine |
heart SMP-ATPase |
|
affect |
Positive |
maximal inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
2 mol inhibitor/mol F0 |
|
bovine |
heart H+-translocation |
|
affect |
Positive |
maximal inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
1 mol inhibitor/mol F0 |
|
E. coli |
membrane H+-translocation |
|
affect |
Positive |
maximal inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
|
|
|
|
|
affect |
Positive |
|
170 |
woodward's reagent k |
|
|
|
|
|
affect |
Positive |
|
170 |
woodward's reagent k |
|
|
|
|
|
affect |
Positive |
|
170 |
cyclophilin D |
|
|
|
|
|
affect |
Positive |
|
171 |
triclosan |
0.5 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
triclosan |
0.5 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
triclosan |
0.5 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
Benzo(A)Pyrene |
100 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
Benzo(A)Pyrene |
1000 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
phenanthrene |
500 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
phenanthrene |
100 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
phenanthrene |
500 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
increase |
Positive |
|
85 |
fluoranthene |
100 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
fluoranthene |
100 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
fluoranthene |
100 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
85 |
fluoranthene |
100 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
increase |
Positive |
|
85 |
Phenanthrenequinone |
2 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
benz(a)anthracene-7,12-dione |
5 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
9,10-anthraquinone |
20 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
1,9-benz-10-anthrone |
10 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
Phenanthrenequinone |
2 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
xanthone |
20 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
benz(a)anthracene-7,12-dione |
5 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
1,9-benz-10-anthrone |
10 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
9,10-anthraquinone |
20 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
1,9-benz-10-anthrone |
10 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
xanthone |
20 µM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
86 |
triclosan |
30 μM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
89 |
triclosan |
30 μM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
89 |
triclosan |
30 μM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
increase |
Positive |
|
89 |
2,4-dinitrophenol |
0.5 μM / 6 hpf |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
increase |
Positive |
|
90 |
2,4-dinitrophenol |
0.5 μM / 48 hpf |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
90 |
2,4-dinitrophenol |
0.5 μM / 24 hpf |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
affect |
Positive |
|
90 |
2,4-dinitrophenol |
0.5 μM / 48 hpf |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
90 |
2,4-dinitrophenol |
0.5 μM / 24 hpf |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
90 |
2,4-dinitrophenol |
0.5 μM / 24 hpf |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
90 |
2,4-dinitrophenol |
0.5 μM / 24 hpf |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
increase |
Positive |
|
90 |
quercetin |
1 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
91 |
quercetin |
1 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
91 |
quercetin |
10 µg/l |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
91 |
diquat |
100 μM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
92 |
diquat |
100 μM |
|
zebrafish |
|
XFe24 Extracellular Flux Analyzer |
decrease |
Positive |
|
92 |
Rotenone |
0.07 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Rotenone |
0.04 nmol/mg |
|
bovine |
mitochondria |
NADH–O2 |
decrease |
Positive |
IC50 |
94 |
Deguelin |
4.2 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
95 |
Piericidin A |
0.06 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Piericidin A |
0.03 nmol/mg |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
94 |
Ubicidin-3 |
0.17 nmol/mg |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
96 |
Rolliniastatin-1 |
0.03 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
98 |
rolliniastatin-2 |
0.06 nmol/mg |
|
bovine |
mitochondria |
NADH–Q-1 |
decrease |
Positive |
IC50 |
98 |
Otivarin |
0.2 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
98 |
phenoxan |
0.04 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Thiangazole |
0.04 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
myxalamid pi |
15 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
phenalamid a2 |
0.6 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Aurachin a |
8.0 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Myxothiazol |
20 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
99 |
stigmatellin |
100 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
99 |
TDS |
40 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
99 |
aureothin |
0.3 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Cochlioquinone b |
83 nmol/mg |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
100 |
strobilurin a |
>100 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
99 |
pterulone |
36 μM |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
101 |
Capsaicin |
20–30 μM |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
102 |
Capsaicin |
20–30 μM |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
102 |
Rhein |
30 μM |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
104 |
Papaverine |
5 μM |
|
bovine |
mitochondria |
NADH–Q-1 |
decrease |
Positive |
IC50 |
30 |
Ubiquinone-2 |
2 μM |
|
bovine |
mitochondria |
NADH–Q-1 |
decrease |
Positive |
IC50 |
106 |
Ubiquinone-3 |
40 μM |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
107 |
Idebenone |
0.4 μM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
106 |
Pyridaben |
2.4 nM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
Fenpyroximate |
4.6 nM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
Fenpyroximate |
18 nM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
103 |
Tebufenpyrad |
6 nM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
fenazaquin |
20 nM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
109 |
Benzimidazole |
3 nM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
94 |
cyhalothrin |
0.6 μM |
|
|
|
NADH–DQ |
decrease |
Positive |
IC50 |
110 |
6-chloro-benzothiadiazole |
0.1 mM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
111 |
2M-TIO |
40 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
112 |
amytal |
0.2 mM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
112 |
meperidine |
0.1 mM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
MPP+ |
0.3 mM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
114 |
MPP+ |
2–4 mM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
115 |
Rosiglitazone |
1uM |
24 and 48 hours |
Murine |
3T3-L1 adipocytes differentiated |
96-well BD Oxygen Biosensor System plates |
increase |
Positive |
|
179 |
4'-decyl-mpp+ |
1.7 μM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
115 |
MQ18 |
0.2 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
116 |
2-methylharmine |
0.18 mM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
117 |
TIQ |
2 mM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
118 |
Haloperidol |
3 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
119 |
HPP+ |
15 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
119 |
Dequalinium Chloride |
11 μM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
120 |
Cinnarizine |
5–10 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
121 |
para-nonylphenol |
20 μM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
108 |
Catechol |
0.4 mM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
108 |
CCCP |
85 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
Erythrosin 5'-iodoacetamide |
20 nM |
|
|
|
NADH–O2 |
decrease |
Positive |
IC50 |
126 |
Safranine |
17 μM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
127 |
dioc5(3) |
1.5 μM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
127 |
dioc6(3) |
80 nM |
|
|
|
NADH–O2 |
decrease |
Positive |
IC50 |
126 |
Diphenyleneiodonium chloride |
0.23 μM |
|
|
|
NADH–Q-1c |
decrease |
Positive |
IC50 |
128 |
N,N'-dicyclohexylcarbodiimide |
0.1 mM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
129 |
o-phenanthroline |
0.25 mM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
130 |
Leucinostatin |
11 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
131 |
Leucinostatin |
2 μg inhibitor/ml |
|
spinach |
chloroplast |
|
decrease |
Positive |
IC50 |
132 |
Leucinostatin |
0.1-0.4 μg/mg protein |
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
133 |
efrapeptins |
0.56 mol/mol F1 |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
IC50 |
134 |
efrapeptins |
70 ng/ml |
|
C. asciculate |
MF1-ATPase |
|
decrease |
Positive |
IC50 |
135 |
efrapeptins |
0.3 μM |
|
human |
umbilical vein endothelial cell, nonmitochondrial ATP synthase |
|
decrease |
Positive |
IC50 |
136 |
efrapeptins |
0.5 μg/ml |
|
R. rubrum |
chromatophores |
|
decrease |
Positive |
IC50 |
137 |
efrapeptins |
0.05-0.5 μg of inhibitor/mg protein |
|
T. pyriformis |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
138 |
efrapeptins |
21.5 μM |
|
|
EF1-ATPase |
|
decrease |
Positive |
ki |
139 |
efrapeptins |
10 nM |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
kd |
134 |
efrapeptins |
2.4 mol inhibitor/mol enzyme |
|
bovine |
heart SMP-ATPase |
|
decrease |
Positive |
complete inhibition |
134 |
resveratrol |
27.7 μM |
|
rat |
brain SMP, ATP synthesis |
|
decrease |
Positive |
|
140 |
resveratrol |
14 μM |
|
rat |
liver MF1-ATPase |
|
decrease |
Positive |
|
141 |
resveratrol |
19 μM |
|
rat |
brain M F0F1-ATPase |
|
decrease |
Positive |
|
140 |
resveratrol |
6.4 μM |
|
bovine |
bovine heart MF1-ATPase |
|
decrease |
Positive |
|
142 |
resveratrol |
2 μM |
|
human |
human umbilical vein endothelial cell, nonmitochondrial ATP synthase, ATP synthesis |
|
decrease |
Positive |
|
136 |
Diethylstilbestrol |
10 μM |
|
rat |
liver MF0F1-ATPase |
|
decrease |
Positive |
|
143 |
Diethylstilbestrol |
10-25 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
|
141 |
SITS |
∼1.3 μM |
|
V. parahaemolyticus |
F0F1-ATPase |
|
decrease |
Positive |
|
144 |
SITS |
25 μM |
|
V. parahaemolyticus |
F1-ATPase |
|
decrease |
Positive |
95% inhibition |
145 |
DIDS |
20.9 μM |
|
rat |
liver MF1ATPase |
|
decrease |
Positive |
|
146 |
quercetin |
5 kmol/mol |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
IC50 |
147 |
quercetin |
85 μM |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
IC50 |
148 |
quercetin |
180 μM |
|
bovine |
heart SMP-ATPase |
|
decrease |
Positive |
IC50 |
148 |
quercetin |
50 μM |
|
rat |
brain F0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
quercetin |
3 μM |
|
rat |
liver F1-ATPase |
|
decrease |
Positive |
IC50 |
141 |
quercetin |
2 kmol/mola |
|
spinach |
CF1-ATPase |
|
decrease |
Positive |
|
147 |
quercetin |
2.6 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
131 |
quercetin |
0.2 mM |
|
pig |
heart MF1-ATPase |
|
decrease |
Positive |
Ki |
149 |
quercetin |
27 μM |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
Kd |
147 |
quercetin |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
decrease |
Positive |
46% inhibition |
150 |
kaempferol |
55 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
morin |
60 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
apigenin |
105 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
genistein |
55 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
genistein |
50 μM |
|
rat |
liver F1-ATPase |
|
decrease |
Positive |
10% inhibition |
141 |
Biochanin A |
65 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
Daidzein |
127 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
151 |
Oligomycin |
152 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
decrease |
Positive |
IC50 |
152 |
Oligomycin |
7.1 μg inhibitor/mg protein |
|
C. asciculate |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
131 |
Oligomycin |
2.0-3.0 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
153 |
Oligomycin |
0.3 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
decrease |
Positive |
IC50 |
154 |
Oligomycin |
15 ng inhibitor/mg protein |
|
N. crassa |
SMP-ATPase |
|
decrease |
Positive |
Ki |
155 |
Oligomycin |
0.21 μM |
|
bovine |
heart MF0F1-ATPase |
|
decrease |
Positive |
Ki |
156 |
Oligomycin |
0.4 μg inhibitor/mg protein |
|
bovine |
heart SMP-ATPase |
|
decrease |
Positive |
95% inhibition |
157 |
Oligomycin |
0.5 μg/ml |
|
rat |
liver SMP-ATPase |
|
decrease |
Positive |
75% inhibition |
158 |
peliomycin |
4.5 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
153 |
venturicidin B |
9 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
decrease |
Positive |
IC50 |
152 |
venturicidin B |
11 μg inhibitor/mg protein |
|
E. coli |
membrane-bound ATPase |
|
decrease |
Positive |
IC50 |
152 |
venturicidin B |
0.13 μg inhibitor/mg protein |
|
|
|
|
decrease |
Positive |
IC50 |
153 |
venturicidin B |
0.06-0.18 (A and B) and 11.0 (X) μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
159 |
venturicidin B |
5-11 μg inhibitor/mg protein |
|
T. pyriformis |
|
|
decrease |
Positive |
IC50 |
138 |
venturicidin B |
3.0 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
131 |
venturicidin B |
0.5 μM |
|
spinach |
thylakoids |
|
decrease |
Positive |
IC50 |
160 |
venturicidin B |
0.5 μM |
|
spinach |
thylakoids, ATPase |
|
decrease |
Positive |
IC50 |
160 |
ossamycin |
1.3 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
153 |
ossamycin |
46 μg of inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
decrease |
Positive |
IC50 |
152 |
ossamycin |
8 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
decrease |
Positive |
IC50 |
154 |
apoptolidin |
4-5 μM |
|
S. cerevisiae |
membrane-bound F0F1-ATPase |
|
decrease |
Positive |
Ki |
161 |
apoptolidin |
18 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
decrease |
Positive |
IC50 |
154 |
cytovaricin |
1 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
decrease |
Positive |
IC50 |
154 |
cytovaricin |
0.4 μM |
|
S. cerevisiae |
membrane-bound F0F1-ATPase |
|
decrease |
Positive |
Ki |
161 |
ossamycin |
0.8 μM |
|
|
60 human cancer cell lines of the National Cancer Institute |
|
decrease |
Positive |
mean |
184 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
p < 0.01 |
3 |
Perhexiline |
|
|
|
|
|
affect |
Positive |
|
227 |
benzarone |
20 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzarone |
50 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
atpenin a5 |
|
|
bovine |
heart mitochondria |
|
affect |
Positive |
|
192 |
Carboxin |
|
|
bovine |
heart mitochondria |
|
affect |
Positive |
|
192 |
Thenoyltrifluoroacetone |
|
|
bovine |
heart mitochondria |
|
affect |
Positive |
|
192 |
HQNO |
|
|
bovine |
heart mitochondria |
|
affect |
Positive |
|
192 |
benzbromarone |
0.1 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzbromarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Nimesulide |
|
|
|
|
|
|
Positive |
|
197 |
Cephaloglycin |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Imipenem |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Chlorpromazine |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Haloperidol |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Clozapine |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Nefazodone |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Metformin |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Phenformin |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Troglitazone |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Rosiglitazone |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Pioglitazone |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Efavirenz |
|
|
|
|
|
|
Positive |
|
197 |
Barbiturate |
|
|
|
|
|
decrease |
Positive |
|
197 |
Phenformin |
100 nmol/mg mitochondrial protein |
|
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
Rotenone |
10–100 nmol |
|
|
SK-N-MC Neuroblastoma cells |
|
decrease |
Positive |
|
242 |
Lead |
1%,2%,4% in oral chow |
|
Wistar rats |
|
|
|
Positive |
|
242 |
buformin |
100 nmol/mg mitochondrial protein |
40 min preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
Cisplatin |
|
|
|
|
|
decrease |
Positive |
|
307 |
Cyclophosphamide |
|
|
|
|
|
decrease |
Positive |
|
307 |
2‐Butylbenzofuran |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Lonidamine |
|
|
|
|
|
|
Positive |
|
249 |
Yohimbine |
|
|
mouse |
neuron |
Oxygen consumption rate (OCR) or extracellular acidification rate (ECAR) measurements from permeabilized neurons and isolated brain mitochondria were performed using the XF96 Extracellular Flux analyzer (Seahorse Bioscience). |
increase |
Positive |
|
269 |
Dyclonine |
|
|
mouse |
neuron |
Oxygen consumption rate (OCR) or extracellular acidification rate (ECAR) measurements from permeabilized neurons and isolated brain mitochondria were performed using the XF96 Extracellular Flux analyzer (Seahorse Bioscience). |
increase |
Positive |
|
269 |
2‐Butylbenzofuran |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Perhexiline |
100 μM |
|
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
increase |
Positive |
p < 0.01 |
193 |
Perhexiline |
200 μM |
|
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
increase |
Positive |
p < 0.01 |
193 |
tacrolimus |
50 µg/ml |
12hr |
|
INS-1 cells |
XF24 Extracellular Flux Analyzer |
decrease |
Positive |
|
322 |
tacrolimus |
50 µg/ml |
12hr |
|
INS-1 cells |
XF24 Extracellular Flux Analyzer |
decrease |
Positive |
|
322 |
tacrolimus |
50 µg/ml |
12hr |
|
INS-1 cells |
XF24 Extracellular Flux Analyzer |
decrease |
Positive |
|
322 |
tacrolimus |
50 µg/ml |
12hr |
|
INS-1 cells |
XF24 Extracellular Flux Analyzer |
decrease |
Positive |
|
322 |
tacrolimus |
1 μM |
|
rat |
isolated kidney mitochondria |
Oxygen consumption was measured with a Clark‐type electrode |
decrease |
Positive |
10% |
323 |
rapamycin |
1 μM |
|
rat |
isolated kidney mitochondria |
Oxygen consumption was measured with a Clark‐type electrode |
decrease |
Positive |
11% |
323 |
tacrolimus |
3.4E−11 M and 2.3E−8 M |
|
rat |
isolated kidney mitochondria |
Oxygen consumption was measured with a Clark‐type electrode |
decrease |
Positive |
EC50 ; maximal inhibitory effect was about 20% |
323 |
rapamycin |
4.4×10−10 M |
|
rat |
isolated kidney mitochondria |
Oxygen consumption was measured with a Clark‐type electrode |
decrease |
Positive |
EC50 ; maximal inhibitory effect was about14% |
323 |
tacrolimus |
1 μM |
|
rat |
isolated kidney mitochondria |
Oxygen consumption was measured with a Clark‐type electrode |
decrease |
Positive |
|
323 |
rapamycin |
1 μM |
|
rat |
isolated kidney mitochondria |
Oxygen consumption was measured with a Clark‐type electrode |
decrease |
Positive |
|
323 |
MG-132 |
20 μM |
6 hr |
|
HeLa cells |
Mitochondrial respiration was calculated by measuring oxygen consumption rate (OCR) and proton flux under a series of conditions using a Seahorse Flux analyzer. |
inhibit |
Positive |
|
291 |
Diazepam |
70 μg/ml |
|
|
pig kidney embryo cells |
polarographic cell (1.2 ml) |
inhibit |
Positive |
|
293 |
Cadmium |
50-500 μM |
3hr |
rat |
PC12 cells |
Cell respiration was determined polarographically with the help of Clark oxygen electrode |
decrease |
Positive |
|
300 |
Mercury |
10-50 μM |
3hr |
rat |
PC12 cells |
Cell respiration was determined polarographically with the help of Clark oxygen electrode |
decrease |
Positive |
|
300 |
Copper |
50 μM |
|
rat |
PC12 cells |
Cell respiration was determined polarographically with the help of Clark oxygen electrode |
decrease |
Positive |
|
300 |
Ketoconazole |
I50=32, 74, 65, 75, 500μM for substrates Glutamate/Malate, Pyruvate/Malate, Ornithine/Malate, Arginine/Malate and Succinate repectively |
|
rat |
liver mitochondria |
Clark electrode |
inhibit |
Positive |
|
303 |
Miconazole |
I50=100, 160, 160, 170, 150 μM for substrates Glutamate/Malate, Pyruvate/Malate, Ornithine/Malate, Arginine/Malate and Succinate repectively |
|
rat |
liver mitochondria |
Clark electrode |
inhibit |
Positive |
|
303 |
Amiodarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Gentamicin |
5mM |
10min |
rat |
isolated rat liver (and kidney) mitochondria |
Oroboros O2K Oxygraph, complex II-based state 4 respiration |
increase |
Positive |
|
316 |
Gentamicin |
5mM |
10min |
rat |
isolated rat liver (and kidney) mitochondria |
Oroboros O2K Oxygraph, complex II-based state 3u respiration |
decrease |
Positive |
|
316 |
Gentamicin |
5mM |
10min |
rat |
isolated rat liver mitochondria |
Oroboros O2K Oxygraph, complex I-based state 4 respiration |
increase |
Positive |
|
316 |
Gentamicin |
5mM |
10min |
rat |
isolated rat liver mitochondria |
Oroboros O2K Oxygraph, complex I-based state 3u respiration |
decrease |
Positive |
|
316 |
Gentamicin |
5mM |
10min |
rat |
isolated rat liver (and kidney) mitochondria |
Oroboros O2K Oxygraph |
reduce |
Positive |
|
316 |
Berberine |
1-10 µM |
|
|
isolated rat muscle mitochondria |
Clark type oxygen electrode (Strathkelvin Instruments) |
decrease |
Positive |
|
328 |
Acetaminophen |
348.5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Acetylsalicylic acid |
> 800 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
alpidem |
25.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Amantadine |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Ambroxol |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Amiodarone |
45.92 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Amoxicillin |
90.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
increase |
Positive |
EC20 |
36 |
Ampicillin |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Antipyrine |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Arsenic trioxide |
< 50 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Biotin |
44.5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
lumiracoxib |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
bisacodyl |
50.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
estradiol acetate |
> 200 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Bupivacaine |
60.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Busulfan |
169.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Butein |
29.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Caffeine |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Capsaicin |
15 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Carbamazepine |
53.4 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Cefixime |
41.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Chlorambucil |
138.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Ciprofloxacin |
195.0 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
increase |
Positive |
EC20 |
36 |
Clodronate |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Clotrimazole |
2.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
curcumin |
> 200 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Daunorubicin |
12.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
dexamethasone valerate |
> 200 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Diazoxide |
4.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Diclofenac |
9.1 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Diflunisal |
9.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Doxorubicin |
15.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
erlotinib |
328.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Fluconazole |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Flufenamic Acid |
1.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
gefitinib |
269.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
genistein |
81.3 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Glimepiride |
16.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Gossypol |
30.3 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Ibuprofen |
170.1 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
imipramine |
75.5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
increase |
Positive |
EC20 |
36 |
Indomethacin |
25.2 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Isoniazid |
59.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Ketoconazole |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Lamivudine |
160.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Lidocaine |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Lonidamine |
18.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
lovastatin |
4.4 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
lumiracoxib |
26.3 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Manganese |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Mefenamic acid |
10.1 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Metformin |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Mitomycin |
4.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Nicotine |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
nifuroxazide |
61.5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Nimesulide |
< 25 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Nitrofurantoin |
232.3 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Perhexiline |
88.4 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Piroxicam |
224.5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
pravastatin |
5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
propylparaben |
63 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Pyrazinamide |
107.5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
resveratrol |
7.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
riboflavin |
264.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
rifampicin |
124.1 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
ritonavir |
35.5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Salicylic acid |
354.4 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Simvastatin |
1.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
sorafenib |
283.4 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Sulindac |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Oligomycin |
8 nM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
aurovertin B |
1.5 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
p < 0.05 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.05 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Chlorpromazine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Chlorpromazine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Chlorpromazine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Diclofenac |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.01 |
3 |
Cefixime |
216.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Chlorambucil |
140.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
gefitinib |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.05 |
3 |
gefitinib |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Ibuprofen |
132.1 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
imipramine |
18.3 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
increase |
Positive |
EC20 |
36 |
Ketoconazole |
2.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Salicylic acid |
120.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Sulindac |
35.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Tolfenamic Acid |
238.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
increase |
Positive |
EC20 |
36 |
Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Valproic Acid |
44.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Zidovudine |
242.0 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
increase |
Positive |
EC20 |
36 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
26.6 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
4 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
1.6 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
29 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
26 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
15 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
8.1 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
30 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
30 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
IC50 |
3 |
Amiodarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Amiodarone |
10 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Amiodarone |
20 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Amiodarone |
50 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Amiodarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzbromarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzbromarone |
1 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzbromarone |
10 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzbromarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Zidovudine |
|
|
|
|
|
Interfere |
Positive |
|
307 |
Acyclovir |
|
|
|
|
|
Interfere |
Positive |
|
307 |
Ganciclovir |
|
|
|
|
|
Interfere |
Positive |
|
307 |
Zalcitabine |
|
|
|
|
|
Interfere |
Positive |
|
307 |
tetracyclines |
|
|
|
|
|
decrease |
Positive |
|
307 |
Ciprofloxacin |
|
|
|
|
|
decrease |
Positive |
|
307 |
Ciprofloxacin |
|
|
|
|
|
decrease |
Positive |
|
307 |
2‐Butylbenzofuran |
50 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
4 |
benzarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Amiodarone |
10 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Amiodarone |
20 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Clozapine |
|
|
|
|
|
decrease |
Positive |
|
307 |
Amiodarone |
50 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
sertraline |
|
|
rat |
brain mitochondria |
|
decrease |
Positive |
|
307 |
Fluoxetine |
|
|
rat |
brain mitochondria |
|
decrease |
Positive |
|
307 |
sertraline |
|
|
rat |
liver mitochondria |
|
decrease |
Positive |
|
307 |
Fluoxetine |
|
|
rat |
liver mitochondria |
|
decrease |
Positive |
|
307 |
benzbromarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
sertraline |
|
|
|
|
|
decrease |
Positive |
|
307 |
Fluoxetine |
|
|
|
|
|
decrease |
Positive |
|
307 |
benzbromarone |
1 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
benzbromarone |
10 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
Flufenamic Acid |
2.9 ± 0.3 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Tolfenamic Acid |
3.4 ± 0.6 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Mefenamic acid |
17.9 ± 2.2 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Meloxicam |
22.8 ± 2.8 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Sudoxicam |
37.4 ± 3.0 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Piroxicam |
69.0 ± 7.2 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Diflunisal |
6.7 ± 1.3 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Diclofenac |
56.3 ± 4.9 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Sulindac |
> 100 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Sulindac sulfide |
25.7 ± 4.5 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Nimesulide |
2.6 ± 0.2 |
|
rat |
isolated rat liver mitochondria |
State 2 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
UC50 (nmol/mg mitochondrial protein) |
40 |
Sulindac sulfide |
39.8 ± 2.9 |
|
rat |
isolated rat liver mitochondria |
State 3 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
IC50 (nmol/mg mitochondrial protein) |
40 |
atorvastatin |
|
|
|
C2C12 myoblasts |
|
affect |
Positive |
|
180 |
Cerivastatin |
100uM |
|
|
C2C12 myoblasts |
measured ubiquinol:cytochrome c oxidoreductase activity in broken C2C12 mitochondria after acute statin exposure at a fixed concentration for all compounds |
decrease |
Positive |
|
180 |
pitavastatin |
100uM |
|
|
C2C12 myoblasts |
measured ubiquinol:cytochrome c oxidoreductase activity in broken C2C12 mitochondria after acute statin exposure at a fixed concentration for all compounds |
decrease |
Positive |
|
180 |
lovastatin |
100uM |
|
|
C2C12 myoblasts |
measured ubiquinol:cytochrome c oxidoreductase activity in broken C2C12 mitochondria after acute statin exposure at a fixed concentration for all compounds |
decrease |
Positive |
|
180 |
Simvastatin |
100uM |
|
|
C2C12 myoblasts |
Measured ubiquinol:cytochrome c oxidoreductase activity in broken C2C12 mitochondria after acute statin exposure at a fixed concentration for all compounds. The lactone forms of the indicated statins were included in the assay medium at their cytotoxic EC50 concentration for measurement of their effect on the catalytic capacity. |
decrease |
Positive |
|
180 |
Simvastatin |
200uM |
|
bovine |
heart mitochondria |
Reduction of the CIII cytochromes c1 and b was determined spectrophotometrically in bovine heart mitochondria. |
affect |
Positive |
p < 0.01 |
180 |
Rotenone |
263±43 nM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
decrease |
Positive |
EC50 |
7 |
Antimycin A |
4±0.2 nM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
decrease |
Positive |
EC50 |
7 |
Oligomycin |
0.92± 0.18 μM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
decrease |
Positive |
EC50 |
7 |
FCCP |
54±7 nM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
increase |
Positive |
EC50 |
7 |
2-Deoxy-D-glucose |
150 mM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
increase |
Positive |
EC50 |
7 |
Tolcapone |
3.7 μM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
increase |
Positive |
EC50 |
7 |
Entacapone |
33 μM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
increase |
Positive |
EC50 |
7 |
Nilutamide |
66 μM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
decrease |
Positive |
EC50 |
7 |
Flutamide |
> 100 μM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
decrease |
Positive |
EC50 |
7 |
Chlorpromazine |
> 300 μM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
increase |
Positive |
EC50 |
7 |
Diflunisal |
15 μM |
2 minutes |
human |
HepG2 |
Measurement of OCR |
increase |
Positive |
EC50 |
7 |
Benoxaprofen |
30 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
decrease |
Positive |
EC50 |
7 |
Troglitazone |
> 100 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
decrease |
Positive |
EC50 |
7 |
Troglitazone |
10-50 μM |
|
ZDF fa/fa rat & ZDF lean rat |
isolated liver mitochondria |
OCR and measured using a fluorescent oxygen probe (Presens) |
decrease |
Positive |
significantly different from control (p < 0.05) |
225 |
Pioglitazone |
25-50 μM |
|
ZDF fa/fa rat & ZDF lean rat |
isolated liver mitochondria |
OCR and measured using a fluorescent oxygen probe (Presens) |
decrease |
Positive |
significantly different from control (p < 0.05) |
225 |
Ciglitazone |
> 100 μM |
2 minutes |
human |
HepG2 |
Measurement of ECAR |
decrease |
Positive |
EC50 |
7 |
Troglitazone |
10 μM |
2 minutes |
feline |
cardiomyocytes |
Measurement of OCR |
increase |
Positive |
EC50 |
7 |
Ciglitazone |
> 100 μM |
2 minutes |
feline |
cardiomyocytes |
Measurement of OCR |
decrease |
Positive |
EC50 |
7 |
Rosiglitazone |
> 100 μM |
2 minutes |
feline |
cardiomyocytes |
Measurement of OCR |
increase |
Positive |
EC50 |
7 |
ionomycin |
|
|
rat |
liver mitochondria |
Oxygen consumption and medium pH were monitored simultaneously with a dual channel Gilson oxygraph equipped with a Clark electrode (Yellow Springs Instruments) and a combination pH electrode (Beckman No. 39030). |
increase |
Positive |
|
202 |
Metformin |
5 mM |
24 hours |
human |
MCF7 |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF7 |
Meassurement of coupled respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
24 hours |
human |
MCF7 |
Meassurement of coupled respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF7 |
Meassurement of non-mitochondrial respiration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
24 hours |
human |
MCF7 |
Meassurement of non-mitochondrial respiration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
mouse |
NMuMG |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
mouse |
NT2196 |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF10A |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF7 |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Tolfenamic Acid |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Metformin |
0.5 mM |
24 hours |
human |
MCF7 |
Meassurement of coupled respiration; Meassurement of uncoupled respiration; cells grown in glucose |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF7 |
Meassurement of coupled respiration; Meassurement of uncoupled respiration; cells grown in galactose |
increase |
Positive |
p < 0.05 |
172 |
Troglitazone |
3.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Metformin |
0.5 mM |
24 hours |
mouse |
NMuMG |
Meassurement of coupled respiration; Meassurement of uncoupled respiration |
increase |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF10A |
Meassurement of coupled respiration; Meassurement of uncoupled respiration |
increase |
Positive |
p < 0.05 |
172 |
Valproic Acid |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Zidovudine |
> 800 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. |
decrease |
Positive |
EC20 |
36 |
Acetaminophen |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Acetylsalicylic acid |
149.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Metformin |
2mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Measurement of Oxygen level; incubated in complex I substrate; added ADP (500 μM) |
decrease |
Positive |
p < 0.05 |
172 |
alpidem |
29.6 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Metformin |
2mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Measurement of Oxygen level; incubated in complex I substrate; added oligomycin (2.5 μg oligomycin/mg mitochondrial protein) |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
2mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Measurement of Oxygen level; incubated in complex I substrate; added FCCP (1.5 μM) |
decrease |
Positive |
p < 0.05 |
172 |
Amantadine |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Ambroxol |
> 200 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Nimesulide |
1 mM |
|
rat; Sprague-Dawley Crl:CD (SD) BR |
lung microsomes |
measurement of oxygen consumption |
increase |
Positive |
p < 0.05 |
11 |
Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used glutamate as substrate |
decrease |
Positive |
p < 0.05; 61% inhibition |
13 |
Amoxicillin |
188.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
increase |
Positive |
EC20 |
36 |
Nitrofurantoin |
50 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used glutamate as substrate |
decrease |
Positive |
p < 0.05; 72% inhibition |
13 |
Nitrofurantoin |
5 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used glutamate as substrate |
decrease |
Positive |
p < 0.05; 38% inhibition |
13 |
Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used β-hydroxybutyrate as substrate |
decrease |
Positive |
p < 0.05 |
13 |
Nitrofurantoin |
50 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used β-hydroxybutyrate as substrate |
decrease |
Positive |
p < 0.05; 60% inhibition |
13 |
Ampicillin |
161.2 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
increase |
Positive |
EC20 |
36 |
Nitrofurantoin |
5 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used β-hydroxybutyrate as substrate |
decrease |
Positive |
p < 0.05 |
13 |
Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used α-ketoghttarate as substrate |
decrease |
Positive |
p < 0.05 |
13 |
Nitrofurantoin |
50 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used α-ketoghttarate as substrate |
decrease |
Positive |
p < 0.05; 70% inhibition |
13 |
Nitrofurantoin |
5 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used α-ketoghttarate as substrate |
decrease |
Positive |
p < 0.05 |
13 |
Antipyrine |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
nitrofurazone |
1mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05; 64% inhibition |
13 |
nitrofurazone |
1mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05; 63% inhibition |
13 |
Arsenic trioxide |
0.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
Nitrofurantoin |
0.005mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
lumiracoxib |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Nitrofurantoin |
0.05mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
Nitrofurantoin |
0.05mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
nitrofurazone |
1mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
bisacodyl |
52.5 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
nitrofurazone |
1mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
estradiol acetate |
> 200 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Bupivacaine |
> 800 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
nitrofurazone |
5μM |
|
mouse; C57B/6J |
mitoplasts |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
nitrofurazone |
5μM |
|
mouse; C57B/6J |
mitoplasts |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
Caffeine |
> 400 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Capsaicin |
15.7 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Carbamazepine |
170.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
increase |
Positive |
EC20 |
36 |
buformin |
25 μM |
24 hours |
human |
HepG2 cells |
Measurement of OCR |
decrease |
Positive |
p < 0.001 |
15 |
Phenformin |
25 μM |
24 hours |
human |
HepG2 cells |
Measurement of OCR |
decrease |
Positive |
p < 0.001 |
15 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
p < 0.001 |
3 |
buformin |
100 nmol/mg mitochondrial protein |
|
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.01 |
3 |
Phenformin |
100 nmol/mg mitochondrial protein |
|
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
Metformin |
500 nmol/mg mitochondrial protein |
40 minutes preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
buformin |
100 nmol/mg mitochondrial protein |
40 minutes preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.01 |
3 |
Phenformin |
100 nmol/mg mitochondrial protein |
40 minutes preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
Clodronate |
227.2 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
buformin |
100 nmol/mg mitochondrial protein |
|
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
Metformin |
66 mM |
|
Bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
IC50 |
15 |
buformin |
11.3 mM |
|
Bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
IC50 |
15 |
Phenformin |
1.2 mM |
|
Bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
IC50 |
15 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.001 |
3 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Metformin |
500 nmol/mg mitochondrial protein |
40 min preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
curcumin |
> 200 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
Phenformin |
100 nmol/mg mitochondrial protein |
40 min preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
p < 0.01 |
3 |
Daunorubicin |
10.9 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
dexamethasone valerate |
> 200 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |
paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Perhexiline |
200 μM |
|
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
increase |
Positive |
p < 0.01 |
193 |
Perhexiline |
100 μM |
|
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
increase |
Positive |
p < 0.01 |
193 |
Diclofenac |
29.8 µM |
60 mins |
mouse |
liver mitochondria |
Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. |
decrease |
Positive |
EC20 |
36 |